Jacob Anderson-Minshall

Have researchers and doctors been looking for HIV in all the wrong places? That’s what the scientists involved in the Collaboratory of AIDS Researchers for Eradication (CARE) certainly believe. CARE is part of an National Institutes of Health-sponsored program, theMartin Delaney Collaboratory: Towards an HIV-1 Cure , named in honor of the late AIDS activist,…

Joe DeCapua

With the success of antiretroviral drugs in treating HIV/AIDS, many infected people are able to lead more normal lives. But treatment is not a cure. A renewed call for a cure was made at the “Why HIV Cure is Still Needed” in Vancouver, Canada. Nicholas Chomont focuses much of his research on finding where the…

Gus Cairns

The Towards an HIV Cure two-day symposium has become a fixture in advance of the International AIDS Society conferences and this one featured a more varied range of experimental approaches than ever in the search for ways of eliminating HIV infection from the body. Dr Daniel Kuritzkes of Harvard Medical School, in his opening talk,…

An 18-year-old French woman is in remission from HIV – despite not having taken any drugs against the virus for 12 years. Doctors have presented the details of her case at an International Aids Society (IAS) conference in Vancouver. It is the world’s first report of long-term remission from HIV in a child. Experts say…

aidsmeds

A natural compound has been found to significantly reduce the rate of reactivation of immune cells latently infected with HIV, suggesting a new potential route to a functional cure for the virus. Publishing their findings in the journal mBio, researchers studied the effects of a compound known as Cortistatin A on latently infected immune cells…

Honor Whiteman

A new study published in PLOS Pathogens provides new insight into how often HIV cells “wake up” among individuals undergoing antiretroviral therapy for the virus, bringing researchers one step closer to getting patients off the treatment for good and into remission. The study was conducted by Prof. Miles Davenport and colleagues from the Kirby Institute…

aidsmeds

Researchers significantly reduced HIV levels in mice with a genetic therapy that induces immune cells to better fight the virus. Publishing their results in Molecular Therapy, researchers engineered a molecule known as a chimeric antigen receptor (CAR) and inserted a gene for that molecule into blood-forming stem cells, which they transplanted into mice genetically engineered…

Supported by

Supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI096109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About NAPWHA

Founded in 1989, The National Association of People with HIV Australia (NAPWHA) is Australia’s peak non-government organisation representing community-based groups of people living with HIV (PLHIV).